Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00745290 · ClinicalTrials.gov registry record · Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty
A Phase 3 study of Postoperative Pain, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 245
- Enrollment target
- 19
- Study locations
NCT00745290 is a Phase 3 study of Postoperative Pain that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 245 participants, roughly in line with the 228-participant average among 63 other Postoperative Pain trials with a reported enrollment target. The trial reports 19 study locations across 11 states.
The verdict
NCT00745290, a Phase 3 study of Postoperative Pain, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 245 participants
- Enrollment target
- 19
- Study locations
Study Summary
The primary objective is to demonstrate that SKY0402 is superior when compared to bupivacaine HCl in the management of postoperative pain for patients undergoing total knee arthroplasty.
Conditions Studied
Interventions
- DRUG Bupivacaine HCl
- DRUG SKY0402
Study Locations (19)
California
- Scripps - La Jolla
- Accurate Clinical Trials, Inc. - Laguna Hills
- Physicans Clinical Research Corp. - Laguna Hills
- Cedars of Sinai Medical Center - Los Angeles
Alabama
- West Alabama Research, Inc. - Birmingham
- Horizon Research Group, Inc., Alabama Orthopaedic Clinic - Mobile
- Drug Research and Analysis Corporation - Montgomery
North Carolina
- CTMG, Inc. - Greenville
- Duke University Medical Center - Raleigh-Durham
Pennsylvania
- Allegheny Pain Management - Altoona
- Ilumina Clinical Associates - Johnstown
Texas
- Texas Orthopedic Specialists, PA - Grapevine
- Memorial Hermann City Hospital - Houston
Arizona
- Sun Health Research Institute, Core Institute - Sun City West
Georgia
- Atlanta Knee and Sports Medicine - Decatur
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00745290
The ClinicalTrials.gov registry entry for NCT00745290 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 228-participant average among 63 other Postoperative Pain trials with a reported enrollment target. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which Bupivacaine HCl is the first listed.
NCT00745290 reports 19 study locations spanning 11 distinct geographic areas - top geographies include California, Alabama, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00745290 about?
NCT00745290 is a clinical study titled "A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty". The primary objective is to demonstrate that SKY0402 is superior when compared to bupivacaine HCl in the management of postoperative pain for patients undergoing total knee arthroplasty.
What is the current status of trial NCT00745290?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 245 participants. The study started on 2008-08. Estimated completion is 2009-02.
What conditions does trial NCT00745290 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT00745290?
The interventions under investigation include: Bupivacaine HCl (DRUG), SKY0402 (DRUG).
Who is sponsoring clinical trial NCT00745290?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00745290 being conducted?
This trial has 19 study locations across Alabama, Arizona, California, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
RADA16 for Adult Tonsillectomy
RECRUITING · Phase 3
-
Perioperative Lidocaine and Ketamine in Abdominal Surgery
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients
COMPLETED · Phase 3
-
Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.